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E-mail address: mejina@fc.miyazaki-u.ac.jp (H. KaMacrophage-stimulating protein (MSP) circulates as a proform protein and requires proteolytic pro-
cessing for activation. Respiratory ciliated cells express the MSP receptor, recepteur d’origine nant-
ais (RON), at the apical surface, which reportedly has an important role in ciliary function. Like RON,
human airway trypsin-like protease (HAT) is also expressed at the apical surface of ciliated cells.
Here we show that HAT cleaves proMSP at the physiological activation site, Arg483-Val484. MSP pro-
cessed by HAT could induce chemotactic responses and morphological changes of peritoneal mac-
rophages. In human respiratory epithelial cells, knock down of HAT expression reduced proMSP
processing and RON autophosphorylation. We suggest that HAT is important for MSP-RON signaling
in the respiratory tract.
Structured summary of protein interactions:
HAT cleaves proMSP by protease assay (View interaction)
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Macrophage-stimulating protein (MSP) was originally identiﬁed
as a plasma protein that induces chemotactic responses of macro-
phages [1]. Mature MSP autophosphorylates its speciﬁc receptor
tyrosine kinase recepteur d’origine nantais (RON) [2]. RON is ex-
pressed not only in macrophages, but also in many types of epithe-
lial cells, and MSP-RON signaling is now believed to be involved in
various pathophysiological settings [2]. In the respiratory tract,
RON is expressed in the ciliated respiratory epithelium and is local-
ized at the apical surface [3]. Activation of RON by MSP induces an
increased ciliary beat frequency [3]. As ciliary motility is critical for
mucociliary transport and cilia dysfunction can cause chronic
respiratory tract infections, MSP-RON signaling is an important
regulatory system in the respiratory tract. In fact, biologically sig-
niﬁcant concentrations of MSP were observed in bronchioalveolarchemical Societies. Published by E
ein; RON, recepteur d’origine
T, human airway trypsin-like
ammonio]-1-propanesulfonic
all interfering RNA
pathology and Regenerative
, University of Miyazaki, 5200
985 856003.
taoka).lavage ﬂuid (1.3–5.8 ng/mL) [3] and in induced sputum of normal
individuals (around 8.4 ng/mL) [4].
MSP belongs to the kringle protein family, whose members con-
tainmultiple copies of a highly conserved triple disulﬁde loop struc-
ture known as the kringle domain. Mature MSP is a disulﬁde-linked
heterodimer with a molecular weight of 80–95 kDa, consisting of a
60 kDa a chain and a 30 kDa b chain [2]. MSP is produced by the
liver and circulates in the plasma as a single-chain precursor
(proMSP) that has no biological activity until the protein is cleaved
into a and b chains at the Arg483-Val484 bond [2]. The amount of
proMSP is relatively high in the serum, with concentrations around
8 lg/mL [4]. Several serum- and cell-derived proteases have been
identiﬁed as candidate convertases for proMSP processing. Among
the serum convertases, hepatocyte growth factor activator (HGFA)
is the most efﬁcient activator [5], while for cellular convertases,
matriptase was reported to be an important activator [6]. Matrip-
tase is a type-II transmembrane protein expressed primarily in epi-
thelial cells [7]. Recently, another type-II transmembrane protease,
hepsin, was identiﬁed as a cellular MSP activator in invasive pros-
tatic cancer cells [8]. Each of these proteases is a trypsin-like serine
protease.
Similar to matriptase and hepsin, human airway trypsin-like
protease (HAT), encoded by the TMPRSS11D gene, belongs to the
type-II transmembrane serine protease superfamily [7]. HAT waslsevier B.V. All rights reserved.
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respiratory tract, HAT is expressed by ciliated epithelial cells
[10]. Unlike matriptase, which is localized on the basolateral sur-
face of epithelial cells, HAT is localized at the basal part of cilia
on the apical surface [10]. Since RON is also localized at the apical
surface of ciliated cells [3], we hypothesized that HAT may be a
proMSP activator that transduces signaling through RON on the
apical surface of ciliated cells. This study aims to elucidate the pro-
cessing activity of HAT towards proMSP.
2. Materials and methods
2.1. Antibodies and recombinant proteins
Anti-HAT mouse polyclonal antibody was purchased from Sig-
ma (St. Louis, MO). Anti-human MSP goat and anti-phosphorylated
RON (Tyr1238/Tyr1239) rabbit polyclonal antibodies were from
R&D Systems (Minneapolis, MN). Anti-RONb (C-20) rabbit poly-
clonal antibody was from Santa Cruz Biotechnology (Santa Cruz,
CA). Recombinant human HAT (active form) and MSP were from
R&D Systems. Preparation of recombinant proMSP protein with a
5  His tag at the C teminus and active-form HGFA was described
previously [5,11].
2.2. Activation of proMSP
ProMSP was incubated at 37 C with various concentrations of
HAT in 20 lL reactions containing 20 mM Tris–HCl (pH 7.6), 50
to 150 mM NaCl, 0.05% 3-[(3-cholamidopropyl)dimethylammo-
nio]-1-propanesulfonic acid (CHAPS) for the indicated time peri-
ods. ProMSP processing activity was determined by immunoblot
analysis [5]. The speciﬁc activity for proMSP processing was ex-
pressed as the enzyme concentration required for the conversion
of 50% of 5 nM proMSP to its mature form, and was designated
as processing concentration 50% (PC50%). To assess the time course
of cleavage by HAT, proMSP (5 nM) was incubated with HAT
(0.5 nM) at 37 C for 0 to 8 h. Immunoblots for MSP were per-
formed as described previously [5].
2.3. N-terminal amino acid sequencing of cleaved proMSP
ProMSP (413 nM) was incubated with 41.3 nM HAT in a 40 lL
reaction containing 20 mM Tris–HCl, 150 mM NaCl, 0.05% CHAPS
(pH 7.6) at 37 C for 8 h. The reaction mixture was run on SDS–
PAGE, after which the proteins were transferred to an Immobilon
membrane (Millipore, Bedford, MA) and stained with 0.1% Coomas-
sie Brilliant Blue in a water/methanol/acetic acid solution
(4.5:4.5:1, v/v). The cleaved MSP protein band was cut and pro-
cessed for N-terminal amino acid sequencing by automated Edman
degradation using the Procise 494 HT Protein Sequencing System
(Applied Biosystems, Foster City, CA).
2.4. Bioassays of MSP
Peritoneal resident macrophages were obtained from C57BL/6
mice as described previously [5]. Brieﬂy, cells were washed and
resuspended in RPMI1640 medium. The macrophage chemotaxis
assay was performed using a polycarbonate membrane (pore size,
5 lm). The bottom wells were ﬁlled with medium containing
proMSP treated or not treated with HAT at 37 C for 2 h. The re-
combinant active-form MSP was used as a positive control. After
incubation at 37 C for 3.5 h, the cells on the upper surface were
wiped off and the membranes were ﬁxed and stained with hema-
toxylin. Migration was quantiﬁed by counting the number of cells
on the lower surface in ten randomly selected ﬁelds (200-fold mag-
niﬁcation). Statistical analyses were carried out using the Statview5.0 program (SAS, Cary, NC). To test the effect of MSP on macro-
phage morphology, murine peritoneal macrophages were cultured
in serum-free RPMI1640 overnight. Non-adherent cells were then
removed and proMSP (1.25 nM) pretreated or not pretreated with
HAT was added to the culture medium. After an additional incuba-
tion at 37 C for 1 h, morphological changes were evaluated by
phase-contrast microscopy [5].
2.5. Silencing of HAT in bronchial epithelial cells
Normal human bronchial epithelial cells (NHBE) were pur-
chased from Clonetics (San Diego, CA). Cells were cultured at
37 C in serum-free bronchial epithelial cell growth medium (Clo-
netics). The culture ﬂasks were pre-coated with 0.03 mg/mL bovine
collagen type 1 (KOKEN, Tokyo, Japan). Small interfering RNAs (siR-
NA) were used for silencing the TMPRSS11D gene encoding HAT.
The sequences of HAT stealth siRNA and its scrambled control
(Invitrogen) were 50-UAAUAAGCCAAUUUGCUGCAGCCUG-30 and
50-AAACAUCUUGAAGUCGAAGUUACGU-30, respectively. Transfec-
tion was performed using Lipofectamine 2000 reagent (Invitrogen).
Forty-eight hours after the transfection, cellular proteins were ex-
tracted with lysis buffer (50 mM HEPES, pH 7.4, 1% Triton X-100,
10% glycerol) with protease inhibitor cocktail (Sigma), 100 mM
NaF and 1 mM Na3VO4, and used for immunoblotting.3. Results
3.1. Processing of proMSP by HAT
The effect of recombinant HAT on the processing of recombi-
nant human proMSP was tested. Incubation of proMSP with HAT
at 37 C led to proMSP processing in a time-dependent manner
and generated a 60 kDa band, presumably the a-chain of mature
MSP as detected by an anti-MSP antibody that recognizes the a-
chain (Fig. 1A). Generation of a 30 kDa band, presumably the b-
chain, was also detected by anti-His tag antibody (Fig. 1B). Cleav-
age site analysis was performed after separating the HAT cleavage
products by SDS–PAGE under reducing conditions. The N-terminal
amino acid sequence of the 30 kDa product was determined to be
Val-Val-Gly-Gly-His, indicating that HAT cleaved proMSP at the
normal processing site, Arg483-Val484. The processing activity of
HAT was dose-dependent and inﬂuenced by NaCl concentration
(Fig. 1C). Similar to HGFA, the physiological activator of pro-MSP
[5], HAT showed more efﬁcient pro-MSP processing at low NaCl
concentrations (50 mM). The concentration of HAT required to
activate 50% of 5 nM proMSP (PC50%) after 4 h at 37 C was
0.04 nM, which was comparable to or a little less efﬁcient than that
of HGFA (PC50%, 0.03 nM), but was muchmore efﬁcient than factor
XIa (PC50%, 0.5 nM; data not shown) [5]. The processing was sup-
pressed at higher NaCl concentrations (Fig. 1C).
3.2. Biological activity of MSP processed by HAT
The biological activity of MSP after HAT processing was deter-
mined using murine peritoneal macrophages. After incubation of
proMSP with HAT, the processed products signiﬁcantly induced
macrophage migration, with an activity comparable to that of com-
mercially available recombinant mature human MSP a/b-heterodi-
mer (Fig. 2A). HAT alone did not detectably induce the chemotactic
response. We also examined the effect of HAT processing on the
culture morphology of mouse peritoneal macrophages. MSP pro-
cessed by HAT induced an elongated, migratory morphology of
macrophages within 1 h, showing an effect similar to that pro-
duced by recombinant mature MSP (Fig. 2B). On the other hand,
murine alveolar macrophages lacking stem cell-derived tyrosin
Fig. 1. Immunoblot analyses of proteolytic cleavage of His-tagged (C-terminus) human proMSP recombinant protein by human HAT. (A) Time-dependent processing of
proMSP (5 nM) by HAT (0.5 nM) in 20 mM Tris buffer (pH 7.6), 150 mM NaCl, 0.05% CHAPS. Anti-MSP a chain antibody was used for detection. (B) Immunoblot of proMSP
with or without HAT treatment (8 h) as described above using anti-His tag antibody. (C) Dose-dependent processing of proMSP (5 nM) by HAT (0–5 nM, 4 h treatment) and
effect of NaCl concentration. The reaction mixtures were incubated at 37 C and the processed products analyzed by immunoblot using anti-MSP a chain antibody.
Fig. 2. Biological activity of MSP processed by HAT. (A) Results of chemotaxis assays. Murine peritoneal resident macrophages (1  105 cells) were placed in the upper well of
a Boyden chamber and incubated for 3.5 h at 37 C. The bottom well contained proMSP (1.25 nM) with or without HAT (0.125 nM) pretreatment (4 h) or recombinant active
MSP (1.25 nM). Values are mean ± standard deviation from triplicate experiments. ⁄p < 0.001 (Mann–Whitney U test). (B) Morphology of macrophages treated with proMSP
(1.25 nM), MSP (1.25 nM) or proMSP (1.25 nM) pretreated with HAT (0.125 nM) for 4 h.
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cessed proMSP (data not shown).
3.3. Cellular HAT is involved in proMSP processing in human
respiratory epithelial cells
We next sought to determine whether cellular HAT is in fact in-
volved in RON activation in human respiratory epithelium. For thispurpose, we used primary cultured normal human bronchial epi-
thelial cells namely, NHBE, which concomitantly express HAT
and RON as determined by RT-PCR (Fig. 3A). Notably, NHBE cells
did not express signiﬁcant levels of the cellular proMSP activators,
such as matriptase and hepsin. Moreover, low but distinct levels of
MSP expression were also observed. Consequently, we observed
steady-state RON phosphorylation in these cells in our culture
conditions even in the absence of serum (Fig. 3B). Therefore, we
Fig. 3. Reduced RON autophosphorylation and proMSP processing after silencing of HAT in NHBE cells. (A) RT-PCR analysis for the expression of cellular activators of proMSP
(HAT, matriptase, hepsin), MSP and RON. (B) Effects of HAT siRNA on RON autophosphorylaton. Same blot membrane was used to detect phosphorylated RON, total RON and
HAT. In total RON, 150-kDa and 170-kDa bands represent b chain of mature two-chain form RON and single-chain proRON proteins, respectively. (C) Effects of HAT siRNA on
processing of endogenous proMSP. Cellular extracts were prepared 3 days after siRNA transfection.
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Transient transfection of HAT siRNA reduced HAT expression by
60% in NHBE cells, and knock down of HAT resulted in the reduc-
tion of RON phosphorylation (Fig. 3B). In fact, the processing of
endogenous proMSP was reduced by 50% after HAT silencing
(Fig. 3C).
4. Discussion
ProMSP is known to be proteolytically converted to its mature
active form by proMSP convertases [2,5]. This activation step
serves as a critical regulatory mechanism in MSP-induced physio-
logical and pathophysiological tissue responses. After proteolytic
cleavage, mature MSP stimulates macrophages expressing RON
by inducing RON autophosphorylation [2]. Epithelial cells also fre-
quently express RON [2,3], and thus it is reasonable to postulate
that MSP has substantial roles in epithelial biology. In this study,
we show that HAT, a type II transmembrane serine protease pre-
dominantly expressed by respiratory ciliated epithelium [7,9,10],
efﬁciently activates human proMSP. As RON is also expressed by
ciliated epithelial cells and a certain amount of MSP is present in
bronchioalveolar lavage ﬂuid [3], we suggest that HAT may be in-
volved in activating proMSP and promoting MSP/RON signaling in
the respiratory tract. Moreover, this study also revealed that low
levels of MSP are expressed by cultured human normal bronchial
epithelial cells, which may create an autocrine loop of MSP/RON.
Matriptase, a type-II transmembrane serine protease widely ex-
pressed by epithelial cells, has been reported to be an important
cellular activator of proMSP [6]. As with respiratory ciliated cells,
in polarized epithelial cells, the plasma membrane is divided by
tight junctions into apical and basolateral portions, with matrip-
tase localized on the basolateral surface [7]. Given the apical local-
ization of RON in ciliated cells [3], it is conceivable that a proMSP
convertase other than matriptase resides at the apical surface. The
polarized expression of HAT on the apical surface [9] supports our
hypothesis that HAT may indeed be a physiological convertase of
proMSP in the respiratory tract.
Regarding the role of MSP/RON signaling in the respiratory
tract, only a limited amount of information is available at present.
MSP-induced RON signaling increases ciliary beat frequency,
which would be important for protecting the respiratory tract from
infectious diseases [3]. In inﬂammatory processes, MSP/RON
signaling appears to have both stimulatory and inhibitory effects
on macrophages. While MSP inducing macrophage spreading,
migration, phagocytosis and cytokine production, it inhibitslipopolysaccharide (LPS)-induced production of inﬂammatory
mediators [1,2,12]. In the lung, MSP differently affects human alve-
olar macrophages from smoker and non-smoker patients, and sig-
niﬁcantly enhances respiratory burst in alveolar macrophages from
smokers, suggesting that MSP may enhance cigarette smoke toxic-
ity [13].
In summary, we demonstrated for the ﬁrst time that HAT is a
potent activator of proMSP. Although proMSP activation can be
mediated by various proteases [5,6,8], we suggest that HAT is the
most convincing activation protease for proMSP in the airway epi-
thelium due to its speciﬁc localization at the apical surface of respi-
ratory ciliated cells, where RON is also expected to be localized.
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